Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > 1Qrt results
View:
Post by subaru1 on May 15, 2024 2:38pm

1Qrt results

Compare to 4qrt 2023.
Revenue increase $640K which is 6,5% not impressive
Gross/profit increase $55k which is 21 % good
Ebitda improve by $630k good.
The road for profatibility is there but speed limit is very low only 6,5% of revenue growth compare to qrt4 2023. Do a comparaison with qrt1 2023 is not good that qrt was a disaster not even 6 millions.
Personnaly i was expecting a much better qrt for the revenue and a Ebitda at 0 or very close.
They are expecting an improvement of 1 to 2 millions for the Ebitda in 2024 that's nice but the market wants more then that. It looks like we will be sitting around $0,08 for a while again, they could have give good guidance for 2qrt, no they are waiting after the US now, so the investors will have to wait after the US too i beleive. Does it worth to wait another 3 months for about the same results????
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities